Clinical Trial Details
EORTC-30021
Back to Clinical Trials Database
Randomized phase II trial of Docetaxel (Taxotere) and Oblimersen vs Taxotere alone in patients with HRPC
| Trial Status | All trial activities ended |
|---|---|
| Dates |
Date of activation: 16-Apr-2004 Date Step1 close: 17-Jan-2006 |
| Data management at EORTC | Yes |
| Design |
Phase 2 Randomized open label |
| Targeted Sample size | EORTC Groups: 102 |
| Treatment | |
| Study Staff | |
| Type of cancer | |
| Participating groups | |
| Protocol summary | http://clinicaltrials.gov/study/NCT00085228 |
| NCT number | NCT00085228 |
| EudraCT | 2004-002094-23 |
